Associate or Professor of Clinical Pediatrics (Division of Hematology-Oncology)-CHLA

University of Southern California; California, Los Angeles (MO, CA); On-site; USD 116,000 - 518,000; Full time

Job summary

An established industry player in pediatric healthcare is seeking a visionary leader for their Division of Hematology-Oncology. This role offers the opportunity to oversee clinical and research initiatives, driving forward innovative therapies for children with cancer. As the Head of the Section of Oncology, you will lead a dedicated team, contributing to a top-ranked program recognized nationally for its excellence. This position promises strong administrative support and resources, making it ideal for those passionate about advancing pediatric oncology care and research. Join a vibrant community committed to diversity and excellence in patient care.

Benefits

Strong administrative support

Research funding

Diversity and inclusion initiatives

Access to cutting-edge research facilities

Qualifications

• Extensive experience in pediatric hematology-oncology is essential.
• Strong background in clinical and translational research.

Responsibilities

• Oversee clinical and research activities in pediatric oncology.
• Lead a team of faculty members in delivering innovative therapies.

Skills

Pediatric Oncology

Clinical Research

Leadership

Multidisciplinary Care

Education

MD or equivalent

Fellowship in Pediatric Hematology-Oncology

Tools

Clinical Trials Management

Research Funding Acquisition

Job description

Associate or Professor of Clinical Pediatrics (Division of Hematology-Oncology)-CHLA
Apply
Keck School of Medicine
Faculty
Los Angeles, California

The University of Southern California (USC), founded in 1880, is the largest private employer in the City of Los Angeles. As an employee of USC, you will be a part of a world-class research university and a member of the "Trojan Family," which is comprised of the faculty, students and staff that make the university what it is.

The Cancer and Blood Disease Institute (CBDI) at Children's Hospital Los Angeles (CHLA) and the Division of Hematology-Oncology within the Department of Pediatrics, Keck School of Medicine, University of Southern California (USC) are recruiting an internationally recognized leader to serve as Head of the Section of Oncology. This individual will oversee clinical and research activities and program expansion in pediatric oncology. They will be expected to conduct research and further advance a leading research program that integrates laboratory and clinical science to develop and deliver innovative oncologic therapies. The position reports to the CBDI Director/Division Chief. Direct reports are approximately 25 faculty members including medical directors of the following programs: Leukemia-Lymphoma, Neuro-Oncology, Solid Tumor, Neuroblastoma, Survivorship and Supportive Care, and Retinoblastoma. The position includes membership at the USC Norris Comprehensive Cancer Center and an academic appointment through USC Keck School of Medicine at the level of Associate Professor or Professor, appropriate to training and experience.

The CBDI is the largest and top-ranked pediatric hematology-oncology program in the western U.S. The U.S. News & World Report ranked the CBDI #3 and CHLA #7 in the nation in 2023-24. The CBDI's Oncology Section saw approximately 900 new oncology patients in 2022. Specialty oncology services include the Leukemia and Lymphoma Program, Neuro-Oncology Program, Solid Tumor Program, Neuroblastoma Program, Retinoblastoma Program, Survivorship and Supportive Care Program, Adolescent and Young Adult Oncology Service, and Radiation Oncology Program. The Section is dedicated to providing the best possible multidisciplinary, individualized care for children with cancer. Section faculty conduct leading-edge research to discover, develop and deliver therapies designed to improve outcomes. The CBDI has a large clinical trials operation that supports programs in hematology, oncology, and transplantation/cellular therapy. Two leading, international pediatric oncology clinical trials consortia are headquartered within the CBDI: Therapeutic Advances in Childhood Leukemia/Lymphoma (TACL) and New Approaches to Neuroblastoma Therapy (NANT). The CBDI is also an active member of 20 leading international consortia. CBDI investigators conduct extensive bench-to-bedside research. Research funding in FY23 totaled $52.5 million with $8.3 million in new awards. The CBDI hosts an ACGME-accredited pediatric hematology-oncology fellowship training program and 1-year advanced subspecialty fellowships in AYA Oncology, Neuro-Oncology, Transplantation/Cellular Therapy and Coagulation.

Strong administrative, clinical, research and financial support will be provided, including staff, infrastructure, endowments, and institutional resources. CHLA and USC are equal opportunity, affirmative action employers. The division greatly values diversity and is committed to building a vibrant and culturally diverse community of faculty that best reflects the patients and families we serve. Individuals from underrepresented groups in medicine are especially encouraged to apply.

The annual base salary range for this position is $116,505.-$517,500. When extending an offer of employment, the University of Southern California considers factors such as (but not limited to) the scope and responsibilities of the position, the candidate's work experience, education/training, key skills, internal peer equity, federal, state, and local laws, contractual stipulations, grant funding, as well as external market and organizational considerations.

Apply here and for further inquiries contact:

Alan S. Wayne, MD

Director, Cancer and Blood Disease Institute

Chief, Division of Hematology-Oncology

Vice Chair, Department of Pediatrics

Children's Hospital Los Angeles

Associate Director, USC Norris Comprehensive Cancer Center

Professor of Pediatrics and Medicine

Keck School of Medicine

University of Southern California

[e-mail]

The University of Southern California strongly values diversity and is committed to equal opportunity in employment. Women and men, and members of all racial and ethnic groups, people with disabilities, and veterans are encouraged to apply.

REQ20138540 Posted Date: 08/21/2023
Apply